Diabetes care is evolving fast.
Drug prices are being capped.
New therapies promise better blood sugar control and even a temporary cure.
Weight loss medications are revealing extra health benefits.
This round-up breaks down today’s key updates for people with diabetes and their families.
Price Caps and Accessibility
India’s National Pharmaceutical Pricing Authority has capped prices for 71 essential drugs, including diabetes and cancer treatments.
Empagliflozin combinations now cost between Rs 14 and Rs 31 per tablet, while Trastuzumab is set at Rs 11,966 per vial.
This move uses the DPCO 2013 to control costs and adjust prices yearly by the Wholesale Price Index.
Non-scheduled drugs can only rise by 10% annually, with the NPPA monitoring and correcting outliers.
Lower out-of-pocket costs help families stay on therapy without skipping doses.
Why it matters: Cheaper pills mean more stable blood sugar control.
When drug costs fall, patients have extra budget for glucose meters, test strips and insulin.
Got unused diabetic supplies? sell your diabetic supplies to DiabeticSupplies.Online for cash.
Cutting-Edge Therapies and Trials
A stem cell infusion by Vertex Pharmaceuticals achieved a temporary cure in 10 of 12 patients with severe Type 1 diabetes.
Called zimislecel, the treatment has let most patients live insulin-free for two years.
Published in the New England Journal of Medicine and shown at the ADA meeting, it targets hypoglycemic unawareness.
This work, led by Dr. Douglas Melton, is a milestone in cell therapy.
Meanwhile, Innovent Biologics inked a deal with JD Health to sell mazdutide—China’s first GLP-1/glucagon dual agonist—online.
Goldman Sachs expects China’s weight loss drug market to hit 40 billion yuan by 2035.
Educating consumers on appetite control and blood sugar balance is central to this partnership.
This could open new access paths for combination therapies on digital platforms (scmp.com).
Weight Loss and Metabolic Research
Metformin isn’t just for diabetes anymore.
A Detroit News report shows people without high blood sugar can lose about 5 pounds with metformin plus diet and exercise.
The drug cuts glucose production by the liver and may prevent diabetes in at-risk adults (detroitnews.com).
New data from an Endocrine Society meeting found weight loss drugs like semaglutide, dulaglutide and tirzepatide raised testosterone in men with obesity or Type 2 diabetes.
A 10% weight drop boosted normal testosterone levels from 53% to 77%.
This highlights reproductive benefits beyond blood sugar control.
But watch for gut side effects.
A cohort study of 24,708 GLP-1 RA users found a 27% higher risk of GERD versus SGLT-2 inhibitors.
Complications rose 55% in smokers and those with prior gastric issues (2minutemedicine.com).
Complications: Heart, Bone, and Gut
Obesity and Type 2 diabetes in teens may weaken bone strength later in life.
A year-long study of 48 adolescents found those with higher insulin and fat gains built less bone quality over time (news-medical.net).
On the heart side, a trial of 255 patients with aortic regurgitation showed diabetes adds extra strain on the left atrium and ventricle.
Diabetics had worse ejection fractions and 42 major adverse cardiac events over 29 months (cardiab.biomedcentral.com).
Nutrition and Lifestyle Advances
Intermittent energy restriction—five days of normal eating plus two very low calorie days—may beat continuous diets for weight loss and blood sugar control in Type 2 diabetes.
In a 90-person trial, IER improved fasting glucose, insulin sensitivity and triglycerides more than other plans (medicalnewstoday.com).
Tai Chi also earned thumbs up.
A meta-analysis of 15 RCTs found the 24-form routine for ≥12 weeks, five times a week, cut fasting glucose, HbA1c, LDL, hs-CRP and inflammatory markers (frontiersin.org).
In complementary therapy, Lannea edulis extract lowered blood sugar and restored pancreatic cells in diabetic rats.
Its flavonoids and saponins slowed glucose absorption and boosted tissue uptake (frontiersin.org).
Insights from Research: Biomarkers and Guidelines
Gene analysis has revealed 30 shared biomarkers between Type 2 diabetes and sarcopenia.
Three key targets—BDH1, FGF9 and LDHA—could guide future diagnostics and treatments (nature.com).
Tracking HbA1c variability in Malaysia’s primary care showed insulin use, high triglycerides and ethnic factors link to swings in blood sugar.
Monitoring variability can flag risk early without extra tests (nature.com).
And new preconception guidelines stress optimizing glucose, blood pressure and nutrition before pregnancy in women with diabetes.
Working closely with a care team cuts risks for mother and baby (contemporaryobgyn.net).
Need Cash for Unused Supplies?
Have extra test strips, lancets or insulin pens?
DiabeticSupplies.Online buys unused diabetic supplies by mail for top dollar.
Turn surplus medical diabetic supplies into cash.
Visit our site to get started today.
FAQ – People Also Ask
Can price caps on diabetes drugs reduce my out-of-pocket costs?
Yes. Price caps limit how much manufacturers can charge, which lowers how much you pay at the pharmacy. Check if your home country or state has similar regulations.
How long does the stem cell trial cure last in Type 1 diabetes?
Patients in the Vertex zimislecel trial have been insulin-free for up to two years. Long-term studies are ongoing to see how durable the effect is.
Is metformin safe for weight loss if I’m not diabetic?
Metformin can aid modest weight loss in non-diabetics. Talk to your doctor about possible side effects and whether it fits your health plan.
What are the risks of GLP-1 receptor agonists?
GLP-1 RAs help weight loss and blood sugar but may raise GERD risk. Smokers and those with gastric issues should watch for reflux.
How do I sell unused diabetic supplies for cash?
Gather your unopened test strips, lancets and insulin pens. Ship them to DiabeticSupplies.Online via our mail-in program. Get paid fast and help reduce medical waste.